1,856
Views
17
CrossRef citations to date
0
Altmetric
Review Article

A historical perspective of immunotoxicology

Pages 197-202 | Received 10 Jul 2013, Accepted 19 Aug 2013, Published online: 01 Oct 2013

References

  • Aryal, B. K., Khuder, S. A., and Schaub, E. A. 2001. Meta-analysis of systemic sclerosis and exposure to solvents. Am. J. Ind. Med. 40:271–274
  • Balls, M., and Hellsten, E. 2000. Statement on the validity of the local lymph node assay for skin sensitization testing. ECVAM Joint Research Centre, European Commission, Ispra. Alt. Lab. Animals 28:366–367
  • Baur, X., and Posch, A. 1998. Characterized allergens causing bakers' asthma. Allergy 6:562–566
  • Bigazzi, P. E. 1997. Autoimmunity caused by xenobiotics. Toxicology 119:1–21
  • Buehler, E. V. 1965. Delayed contact hypersensitivity in the guinea pig. Arch. Derm. 6:701–710
  • Bunderson-Schelvan, M., Pfau, J. C., Crouch, R., and Holian, A. 2011. Non-pulmonary out-comes of asbestos exposure. J. Toxicol. Environ. Health 14:122–152
  • Burns-Naas, L. A., Hastings, K. L., Ladics, G. S., et al. 2008. What's so special about the developing immune system? Int. J. Toxicol. 27:223–254
  • Campbell, J. M. 1932. Acute symptoms following work with hay. Br. Med. J. 2:1143–1144
  • Cooke, W. E. 1927. Pulmonary asbestosis. Br. Med. J. 2:1024–1029
  • Coombs, P. R., and Gell, P. G. 1968. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Clinical Aspects of Immunology. (Gell, P. R., Ed.). Oxford: Oxford University Press, pp. 575–596
  • Coombs, R. R., Hunter, A., Jonas, W. E., et al. 1968. Detection of IgE(IgND) specific antibody (probably reagin) to castor bean allergen by the red cell-linked antigen-antiglobulin reaction. Lancet 1:1115–1118
  • Dean, J. H., Luster, M. I., Boorman, G. A., and Lauer, L. D. 1982. Procedures available to examine the immunotoxicity of chemicals and drugs. Pharmacol. Rev. 34:137–148
  • Dean, J. H., Twerdok, L. E., Tice, R. R., et al. 2001. ICCVAM evaluation of the murine local lymph node assay. II. Conclusions and recommendations of an independent scientific review panel. Regul. Toxicol. Pharmacol. 34:258–273
  • Di Gioacchino, M., Patrarca, C., Lazzirin, F., et al. 2011. Immunotoxicity of nanoparticles. Int. J. Immunopathol. Pharmacol. 24:65S–71S
  • Dostert, C., Petrilli, V., van Bruggen, R., et al. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677
  • Draize, J. H., Woodard, G., and Calvery, H. O. 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 8:377–390
  • Dry, J., Leynadier, F., Pecquet, C., and Chauvin, P. 1989. Immediate hypersensitivity to latex: A new problem. Future perspectives. Bull. Acad. Natl. Med. 173:913–917
  • Fink, J. N. 1976. Hypersensitivity pneumonitis. In: Immunologic and Infectious Reactions in the Lung. (Kirkpatrick, C. H., and Reynolds, H. Y., Eds.). New York: Marcel Dekker Inc., pp. 229–241
  • Gardner, D. E., Miller, F. J., Illing, J.W., and Kirtz, J. M. 1977. Increased infectivity with exposure to ozone and sulfuric acid. Toxicol. Lett. 1:159–164
  • Gilbert, K. M., Griffin, J. M., and Pumford, N. R. 1999. Trichloroethylene activates CD4+ T-cells: Potential role in an autoimmune response. Drug Metab. Rev. 31:901–916
  • Gupta, S., Devanarayan, V., Fincoc, D., et al. 2011. Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics. J. Pharm. Biomed. Anal. 55:878–888
  • Hamilton, R. F. Jr., Thakur, S. A., and Holian, A. 2008. Silica binding and toxicity in alveolar macrophages. Free Rad. Biol. Med. 44:1246–1258
  • Hanifin, J. M., Epstein, W. L., and Cline, M. J. 1970. In vitro studies of granulomatous hyper-sensitivity to beryllium. J. Invest. Dermatol. 55:284–288
  • Hayashi, H., Nishimura, Y., and Hyodo, F. 2011. Dysregulation of autoimmunity caused by silica exposure: Fas-mediated apoptosis in T-lymphocytes derived from silicosis patients. In: Autoimmune Disorders: Symptoms, Diagnosis and Treatment. (Petro, M. E., Ed.). Hauppauge, NY: Nova Science Publishers, pp. 293–301
  • Hirsch, J., Hirsch, B. I., and Ehrlich, P. 1980, Asthma and the discovery of the eosinophil. In: The Eosinophil in Health and Disease. (Mahmoud, A. A., and Austen, K. F., Eds.). New York: Grune and Stratton, pp. 3–23
  • Hirschmann, J. V., Sudhakar, N. J., Pipavath, M. B., and Goodwin, J. S. 2009. Hypersensitivity Pneumonitis: A historical, clinical, and radiologic review. RadioGraphics 29:1921–1938
  • Hollander, A. G. 1953. Byssinosis. Chest 24:674–678
  • House, R. V., and Luebke, R. W. 2007. Immunotoxicology: Thirty years and counting. In: Immunotoxicology and Immunopharmacology, 3rd ed. (Luebke, R., House, R., and Kimber, I., Eds.). Boca Raton, FL: CRC Press, pp. 3–20
  • International Agency for Research on Cancer (IARC). 1997. Silica, some silicate, coal dust and paraaramid fibrils. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 68. Geneva: World Health Organization
  • International Program on Chemical Safety (IPCS). 2006. Principles and methods for assessing autoimmunity associated with exposure to chemicals. Environmental Health Criteria 236. Geneva: World Health Organization, International Program on Chemical Safety. Available online at: http://www.who.int/ipcs/publications/ehc/ehc236.pdf
  • International Program on Chemical Safety (IPCS). 2012. Guidance for immunotoxicity risk assessment for chemicals. Harmonization Project Document No. 10. Geneva: World Health Organization, International Program on Chemical Safety. Available online at: http://www.who.int/ipcs/methods/harmonization/areas/immunotoxicity/en/
  • Jang, J., Lim, D. H., and Choi, I. H. 2010. The impact of nanomaterials in immune system. Immune Network 10:85–91
  • Kamp, D. W., and Weitzman, S. A. 1999. The molecular basis of asbestos induced lung injury. Thorax 54:638–652
  • Kerkvliet, N. I. 2012. TCDD: An environmental immunotoxicant reveals a novel pathway of immunoregulation - a 30-year odyssey. Toxicol. Pathol. 40:138–142
  • Kimber, I., Mitchell, J. A., and Griffin, A. C. 1986. Development of a murine local lymph node assay for the determination of sensitizing potential. Food Chem. Toxicol. 24:585–596
  • Koller, L. D. 1973. Immunosuppression produced by lead, cadmium and mercury. Am J. Vet Res. 34:213–224
  • Kramer, S., Hikel, S. M., Adams, K., et al. 2012. Current status of the epidemiologic evidence linking polychlorinated biphenyls and non-Hodgkin lymphoma, and the role of immune dysregulation. Environ. Health Perspect. 120:1067–1075
  • Ladics, G. S., Smith, C. E., Elliott, G. S., et al. 1998. Further evaluation of the incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats in a standard toxicology study. Toxicology 126:137–152
  • Landsteiner, K., and Jacobs, J. 1935. Studies on sensitization of animals with simple chemical compounds I. J. Exp. Med. 61:643–657
  • Lee, S. L., and Chase, P. H. 1975. Drug-induced systemic lupus erythematosus: A critical review. Semin. Arthritis Rheum. 5:83–103
  • Lee, T. P., and Chang K. L. 1985. Health effects of polychlorinated biphenyls. In: Immunotoxicology and Immunopharmacology. (Dean, J., Luster, M. I., Munson, A. E., and Amos, H., Eds.). New York: Raven Press, pp. 415–422
  • Leung, C. C., Yu, I. T., and Chen, W. 2012. Silicosis. Lancet 379:2008–2018
  • Lopez, M., and Salvaggio, J. 1976. Hypersensitivity pneumonitis: Current concepts of etiology and pathogenesis. Ann. Rev. Med. 27:453–463
  • Luebke, B. 2002. Pesticide-induced immunotoxicity: Are humans at risk? Human Ecol. Risk Assess. 8:293–303
  • Luebke, R. W., Chen, D. H., Dietert, R. R., et al. 2006. The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J. Toxicol. Environ. Health 9:1–26
  • Luster, M. I., Munson, A. E., Thomas, P., et al. 1988. Development of a testing battery to assess chemical-induced immunotoxicity. Fundam. Appl. Toxicol. 10:2–19
  • Luster, M. I., Portier, C., Pait, D. G., et al. 1993. Risk assessment in immunotoxicology. II. Relationship between immune and host resistance tests. Fundam. Appl. Toxicol. 21:71–82
  • Luster, M. I., Portier, C., Pait, D. G., et al. 1992. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:200–210
  • Maeda, M., Miura, Y., Nishimura, Y., et al. 2008. Immunological changes in mesothelioma patients and their experimental detection. Clin. Med.: Circ. Resp. Pulm. 2:11–17
  • Magnusson, B., and Kligman, A. M. 1969. The identification of contact allergens by animal assay. The guinea pig maximization test. Invest. Dermatol. 52:268–276
  • Mapp, C. E. 2005. Genetics and the occupational environment. Curr. Opin. Allergy Clin. Immunol. 5:113–118
  • Martin, A. M., Nolan, D., Gaudieri, S., et al. 2004. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc. Natl. Acad. Sci. USA 101:4180–4185
  • Mehling, A., Eriksson, T., Eltze, T., et al. 2012. Non-animal test methods for predicting skin sensitization potentials. Arch. Toxicol. 86:1273–1295
  • Miller, F. W. 2006. Non-infectious environmental agents and autoimmunity. In: The Autoimmune Diseases. (Rose, N. R., and Mackay I. R., Eds.). St. Louis, MO: Elsevier, pp. 297–307
  • Miller, K., Weintraub, Z., and Kagan, E. 1981. Manifestations of cellular immunity in the rat after prolonged asbestos inhalation. I. Physical interactions between alveolar macrophages and splenic lymphocytes. J. Immunol. 123:1029–1038
  • Munson, A. E., Levy, J. A., Harris, L. S., and Dewey, W. L. 1976. Effects of Δ9-tetrahydrocan-nabinol on the immune system. In: Pharmacology of Marijuana. (Braude, M. C., and Szarza, S., Eds.). New York: Raven Press, pp. 187–199
  • National Research Council (NRC). 1992. Biologic markers in immunotoxicology. A report by the US National Research Council. Washington DC: National Academy Press
  • Organization for Economic Cooperation and Development (OECD). 2002. Test Guideline 429: The Local Lymph Node Assay. Paris: OECD
  • Parker, C. W., de Weck, A. L., Kern, M., and Eisen, H. N. 1962. The preparation and some properties of penicillenic acid derivatives relevant to penicillin hypersensitivity. J. Exp. Med. 115:803–819
  • Pernis, B., Vigliani, E. C., and Selikoff, I. J. 1965. Rheumatoid factor in serum of individuals exposed to asbestos. Ann. NY Acad. Sci. 132:112–120
  • Perry, H. M., Tane, M., and Carmody, S. 1970. Relationship of acetyl transferase activity and anti-nuclear antibodies and toxic syndrome in hypertensive patients with hydralazine. J. Lab. Clin. Med. 76:114–125
  • Pfau, J. C., Sentissi, J. J., Li, S., et al. 2008. Asbestos-induced autoimmunity in C57BL/6 mice. J. Immunotoxicol. 5:129–137
  • Ramazzini, B. 2001. De morbis artificum diatriba [diseases of workers] - 1713. Am. J. Publ. Health 91:1380–1382
  • Richeldi, L., Sorrentino, R., and Saltini, C. 1993. HLA-DPB1 Glutamate 69: A genetic marker of beryllium disease. Science 262:242–244
  • Richerson, H. B., Coon, J. D., and Lubaroff, D. 1995. Adoptive transfer of experimental hyper-sensitivity pneumonitis in the Lewis rat. Am. J. Respir. Crit. Care Med. 151:1205–1210
  • Salter, H. 1866. An analysis of a hundred and fifty unpublished cases of asthma No 2. On the immediate excitants of the asthmatic paroxysm. Lancet ii:259–260
  • Sarzi-Puttini, P., Atzen, F., Capsoni, F., and Lubrano, E. 2005. Drug-induced lupus erythematosus. Autoimmunity 38:507–518
  • Schweigert, M. K., Mackenzie, D. P., and Sarlo, K. 2000. Occupational asthma and allergy associated with the use of enzymes in the detergent industry - a review of the epidemiology, toxicology and methods of prevention. Clin. Exp. Allergy 30:1511–1518
  • Selgrade, M. K., Plopper, C. G., Gilmour, M. I., et al. 2008. Assessing the health effects and risks associated with children's inhalation exposures–asthma and allergy. J Toxicol. Environ. Health 71:196–207
  • Selikoff, I. J., Bader, R. A., Bader, M. E., et al. 1967. Asbestosis and neoplasia. Am. J. Med. 42:487–496
  • Stebbings, R., Poole, S., and Thorpe, R. 2009. Safety of biologics, lessons learnt from TGN1412. Curr. Opin. Biotechnol. 6:673–677
  • Steis, R. G., Smith, J. W., II, Urba, W. J., et al. 1988. Resistance to recombinant interferon-α2a in Hairy Cell Leukemia associated with neutralizing anti-interferon antibodies. New Engl. J. Med. 318:1409–1413
  • Sterner, J. H., and Eisenbud, M. 1951. Epidmiology of beryllium intoxication. Arch. Indust. Hyg. Occup. Med. 4:123–151
  • Strickland, D. H., and Holt, P. G. 2011. T-Regulatory cells in childhood asthma. Trends Immunol. 32:420–427
  • Suntharalingam, G., Perry, M. R., Ward, S., et al. 2006. Cytokine storm in Phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. New Engl. J. Med. 355:1018–1028
  • Tan, E. M. 1974. Drug-induced autoimmune disease. Fed. Proc. 33:1894–1897
  • Uetrecht, P. 2009. Immune-mediated adverse drug reactions. Chem. Res. Toxicol. 22:24–34
  • van Loveren, H., and Vos, J. 1989. Immunotoxicological considerations: A practical approach to immunotoxicity testing in the rat. In: Advances in Applied Toxicology. (Dayan, A., and Paine, A., Eds.). New York: Taylor and Francis, pp. 143–164
  • Vos, J. G., Moore, J. A., and Zinkl, J. G. 1973. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the immune system of laboratory animals. Environ. Health Perspect. 5:149–162
  • Waldhauser, L., and Uetrecht, J. 1991. Oxidation of propyl-thiouracil to reactive metabolites by activated neutrophils: Implications for agranulocytosis. Drug Metab. Disp. 19:354–359
  • White, K., Jennings, P., Murray, P., and Dean, J. 1994. International validation study carried out in 9 laboratories on the immunological assessment of Cyclosporine A in the Fisher 344 rat. Toxicol. In Vitro 8:957–962
  • World Health Organization (WHO). 1996. Principles and methods for assessing direct immunotoxicity. Environmental Health Criteria #180. Geneva: WHO
  • Wilson, S. P., and Cassel, S. L. 2010. Inflammasome mediated auto-inflammatory disorders. Postgrad Med. 122:125–133

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.